The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer.
Mitin, T Choudhury, Ananya
Mitin, T
Choudhury, Ananya
Citations
Altmetric:
Abstract
Patients with localized muscle-invasive bladder cancer (MIBC) can choose to undergo either neoadjuvant chemotherapy followed by radical cystectomy or radiation therapy-based bladder preservation treatment modality with subsequent close cystoscopic surveillance with salvage cystectomy reserved for patients with evidence of local disease recurrence. At the present time, the decision regarding bladder-directed local therapy for MIBC is based on physicians' and patients' preferences, and does not take into account tumor biology. Predictive biomarkers, once validated, could offer a more patient-centered and biology-driven selection of bladder-directed therapies.
Authors
Description
Date
2018-09-14
Publisher
Collections
Keywords
Type
Article
Citation
The role of biomarkers in bladder preservation management of muscle-invasive bladder cancer. 2018, World J Urol